Mangoceuticals (MGRX) Cost of Revenue (2023 - 2026)
Mangoceuticals (MGRX) reported Cost of Revenue of $8218.0 for Q1 2026, down 66.78% on a YoY basis from $24737.0 in Q1 2025, and down 3.44% sequentially from $8511.0 in Q4 2025.
Mangoceuticals (MGRX) Cost of Revenue (2023 - 2026) Analysis & Trends
Mangoceuticals (MGRX) has 4 years of Cost of Revenue data on file, last reported at $8218.0 in Q1 2026.
- For the quarter ending Q1 2026, Cost of Revenue fell 66.78% year-over-year to $8218.0; the trailing twelve-month figure through Mar 2026 stood at $37903.0 (down 61.02% YoY), and the FY2025 full-year result was $54422.0, down 41.67% from the prior year.
- Cost of Revenue declined to $8218.0 in Q1 2026, from $8511.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $53362.0 in Q4 2023 to a low of $2359.0 in Q3 2025.
- A 4-year average of $23910.5 and a median of $21505.0 in 2024 frame the typical range for Cost of Revenue.
- Peak annual rise in Cost of Revenue reached 18.96% in 2025, while the deepest fall reached 89.03% in 2025.
- Tracing MGRX's Cost of Revenue over 4 years: stood at $53362.0 in 2023, then slumped by 60.03% to $21331.0 in 2024, then tumbled by 60.1% to $8511.0 in 2025, then dropped by 3.44% to $8218.0 in 2026.
- Business Quant data shows MGRX's Cost of Revenue at $8218.0 in Q1 2026, $8511.0 in Q4 2025, and $2359.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 220.92 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 260.92 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 98.33 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | 28.07 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 44.67 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 357.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 97.04 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 19.41 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | - |
| 10 | Mangoceuticals | 9.39 Mn | 9.20 Mn | 29,001.00 | 8,218.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,218.00 |
| Mar 31, 2026 | 8,218.00 |
| Dec 31, 2025 | 8,511.00 |
| Dec 31, 2025 | 8,511.00 |
| Sep 30, 2025 | 2,359.00 |
| Sep 30, 2025 | 2,359.00 |
| Jun 30, 2025 | 18,815.00 |
| Jun 30, 2025 | 18,815.00 |
| Mar 31, 2025 | 24,737.00 |
| Mar 31, 2025 | 24,737.00 |
| Dec 31, 2024 | 21,331.00 |
| Dec 31, 2024 | 21,331.00 |
| Sep 30, 2024 | 21,505.00 |
| Sep 30, 2024 | 21,505.00 |
| Jun 30, 2024 | 29,665.00 |
| Jun 30, 2024 | 29,665.00 |
| Mar 31, 2024 | 20,795.00 |
| Mar 31, 2024 | 20,795.00 |
| Dec 31, 2023 | 53,362.00 |
| Dec 31, 2023 | 53,362.00 |